Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в березні 2011 (uk)
- im März 2011 veröffentlichter wissenschaftlicher Artikel (de)
- scientific article published on 31 January 2011 (en)
- artículu científicu espublizáu en xineru de 2011 (ast)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Mario Boccadoro
- Davide Rossi
- Andrea Evangelista
- Angelo M Carella
- Renato Zambello
- Fortunato Morabito
- Francesca Patriarca
- Francesca Elice
- Patrizia Tosi
- Elena Zamagni
- Paola Tacchetti
- Claudia Crippa
- Sara Bringhen
- Vincenzo Callea
- Chiara Nozzoli
- Tommaso Caravita
- Stefano Pulini
- Claudia Polloni
- Giulia Benevolo
- Claudia Cellini
- Valeria Magarotto
- Monica Galli
- Norbert Pescosta
- Fabiana Gentilini
|
rdfs:label
| - Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (en)
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (nl)
|
skos:prefLabel
| - Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (en)
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (nl)
|
name
| - Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (en)
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial (nl)
|
author
| |
author
| |
title
| |
title
| - Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |